Inventor · disambiguated record
Matthew R. Pincus
Also filed as: PINCUS MATTHEW · PINCUS MATTHEW R
17 granted patents·17 pending applications·104 citations·filing 1991–2022
93Inventor score
Files withUNIV NEW YORK STATE RES FOUND14PINCUS MATTHEW R5INNAPHARMA INC3PINCUS MATTHEW3SLH INNOVATIONS LLC3
Top patents by PatentIndex Score
34 records- 0193US7531515B2Peptides selectively lethal to malignant and transformed mammalian cellsUNIV NEW YORK STATE RES FOUND·Filed 2006·Granted May 12, 2009·9 cites·13 claims
- 0291US9765117B2Peptides for treating cancerFIGA ROMEK·Filed 2016·Granted Sep 19, 2017·4 cites·13 claims
- 0390US7745405B2Peptides selectively lethal to malignant and transformed mammalian cellsUNIV NEW YORK STATE RES FOUND·Filed 2007·Granted Jun 29, 2010·9 cites·13 claims
- 0487US8822419B2Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cellsPINCUS MATTHEW R·Filed 2009·Granted Sep 2, 2014·7 cites·7 claims
- 0585US10889619B2Methods for treating cancerSLH INNOVATIONS LLC·Filed 2020·Granted Jan 12, 2021·1 cites·7 claims
- 0682US10400012B2Methods for treating cancerSLH INNOVATIONS LLC·Filed 2017·Granted Sep 3, 2019·1 cites·11 claims
- 0781US10759832B2Methods for treating cancerSLH INNOVATIONS LLC·Filed 2019·Granted Sep 1, 2020·1 cites·8 claims
- 0878US2023174601A1Hdm-2 targeting compositions cause tumor cell necrosis rather than apoptosis of cancer cellsUNIV NEW YORK STATE RES FOUND·Filed 2022·Application pending·0 cites
- 0977US2009286861A1Phenotypic reversion of pancreatic carcinoma cellsUNIV NEW YORK STATE RES FOUND·Filed 2009·Application pending·0 cites
- 1077US2023364178A1Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal CellsUNIV NEW YORK STATE RES FOUND·Filed 2022·Application pending·0 cites
- 1173US7883888B2Peptides selectively lethal to malignant and transformed mammalian cellsRES FOUNDATION & MDASH THE STATE UNIVERSITY OF NEW YORK·Filed 2004·Granted Feb 8, 2011·7 cites·6 claims
- 1273US2020038471A1Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cellsUNIV NEW YORK STATE RES FOUND·Filed 2019·Application pending·0 cites
- 1371US9539327B2Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cellsPINCUS MATTHEW R·Filed 2008·Granted Jan 10, 2017·0 cites·3 claims
- 1470US2021205403A1Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal CellsUNIV NEW YORK STATE RES FOUND·Filed 2021·Application pending·0 cites
- 1569US5910478APeptidomimetics inhibiting the oncogenic action of p21 rasINNAPHARMA INC·Filed 1996·Granted Jun 8, 1999·20 cites·8 claims
- 1666US5624817AMutations in the gene encoding the alpha chain of platelet glycoprotein IbUNIV NEW YORK STATE RES FOUND·Filed 1994·Granted Apr 29, 1997·19 cites·61 claims
- 1765US2008153754A1Phenotypic reversion of pancreatic carcinoma cellsUNIV NEW YORK STATE RES FOUND·Filed 2007·Application pending·0 cites
- 1863US2017209521A1Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cellsUNIV NEW YORK STATE RES FOUND·Filed 2016·Application pending·0 cites
- 1961US9115213B2Phenotypic reversion of pancreatic carcinoma cellsPINCUS MATTHEW·Filed 2012·Granted Aug 25, 2015·0 cites·3 claims
- 2060US5593959AMutations in the gene encoding the alpha chain of platelet glycoprotein IbUNIV NEW YORK STATE RES FOUND·Filed 1993·Granted Jan 14, 1997·19 cites·17 claims
- 2160US2023235308A1Methods, compositions, and prophylactics for treating, ameliorating, or preventing coronavirus disease (covid-19)UNIV NEW YORK STATE RES FOUND·Filed 2021·Application pending·0 cites
- 2260US2020002394A1Hdm-2 targeting compositions cause tumor cell necrosis rather than apoptosis of cancer cellsUNIV NEW YORK STATE RES FOUND·Filed 2019·Application pending·0 cites
- 2360US2004038902A1Peptides selectively lethal to malignant and transformed mammalian cellsFiled 2003·Application pending·0 cites
- 2457US2014371156A1Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cellsPINCUS MATTHEW R·Filed 2014·Application pending·0 cites
- 2556US2017065684A9Phenotypic reversion of pancreatic carcinoma cellsPINCUS MATTHEW·Filed 2015·Application pending·0 cites
- 2655US2005245451A1Peptides selectively lethal to malignant and transformed mammalian cellsPINCUS MATTHEW R·Filed 2004·Application pending·0 cites
- 2753US2010144636A1Peptides derived from ras-p21 and uses thereforUNIV NEW YORK STATE RES FOUND·Filed 2009·Application pending·0 cites
- 2846US2006105956A1Phenotypic reversion of pancreatic carcinoma cellsPINCUS MATTHEW·Filed 2005·Application pending·0 cites
- 2945US2017022288A9Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methodsMICHL JOSEF·Filed 2014·Application pending·0 cites
- 3043US2006258841A1Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methodsMICHL JOSEF·Filed 2004·Application pending·0 cites
- 3132US5990172APeptidomimetics for the treatment of HIV infectionINNAPHARMA INC·Filed 1997·Granted Nov 23, 1999·1 cites·29 claims
- 3232US5840683APeptides inhibiting the oncogenic action of p21 rasINNAPHARMA INC·Filed 1995·Granted Nov 24, 1998·1 cites·10 claims
- 3328US5162499ASynthetic peptides for the treatment of AIDSHETEROCYCLIC RESEARCH INC·Filed 1991·Granted Nov 10, 1992·3 cites·1 claims
- 3421US5270215AColorimetric method for determination of 5-hydroxyindoleacetic acidPINCUS MATTHEW R·Filed 1992·Granted Dec 14, 1993·2 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →